Clinical trial
Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in…
NCT00151801 · S. Andrea Hospital, Other · Unknown status
Key facts
| NCT number | NCT00151801 |
|---|---|
| Title | Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients |
| Official title | Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis |
| Lead sponsor | S. Andrea Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | estroprogestins, interferon-beta 1a |
| Enrollment | 200 |
| Start date | May 1, 2002 |
| Completion | Dec 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Sep 9, 2005 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: